Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yunfang Jiang
A Phase I Trial of Combination Trastuzumab, Lapatinib, and Bevacizumab in Patients With Advanced Cancer
Investigational New Drugs
Oncology
Pharmacology
Microclimatic Impact Analysis of Multi-Dimensional Indicators of Streetscape Fabric in the Medium Spatial Zone
International Journal of Environmental Research and Public Health
Mutagenesis
Public Health
Environmental
Health
Toxicology
Occupational Health
Pollution
Related publications
Phase I Trial of FOLFIRI in Combination With Sorafenib and Bevacizumab in Patients With Advanced Gastrointestinal Malignancies.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Phase I/Ii Trial of Imatinib and Bevacizumab in Patients With Advanced Melanoma and Other Advanced Cancers
Oncologist
Cancer Research
Medicine
Oncology
A Phase II Trial of Erlotinib in Combination With Bevacizumab in Patients With Metastatic Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
Lapatinib in Combination With Capecitabine Versus Continued Use of Trastuzumab in Breast Cancer Patients With Trastuzumab-Resistance: A Retrospective Study of a Chinese Population
BMC Cancer
Cancer Research
Oncology
Genetics
A Phase I Clinical Trial of Vaccination With KIF20A-derived Peptide in Combination With Gemcitabine for Patients With Advanced Pancreatic Cancer
Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer Research
Allergy
Immunology
Pharmacology
Phase I Dose-Escalation Study of Onartuzumab as a Single Agent and in Combination With Bevacizumab in Patients With Advanced Solid Malignancies
Clinical Cancer Research
Cancer Research
Oncology
A Phase I/Ii Study of Poziotinib Combined With Paclitaxel and Trastuzumab in Patients With HER2-positive Advanced Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Phase I Study to Assess the Safety and Tolerability of Olaparib in Combination With Bevacizumab in Patients With Advanced Solid Tumours
British Journal of Cancer
Cancer Research
Oncology
Correction: A Phase I Trial of LY2510924, a CXCR4 Peptide Antagonist, in Patients With Advanced Cancer
Clinical Cancer Research
Cancer Research
Oncology
